Retatrutide 15mg
Retatrutide (LY3437943) is a peptide agonist of the GIP, GLP-1 and glucagon receptors. Structural and receptor-mutagenesis research examines how the same peptide engages all three receptors. This listing contains 15mg of lyophilized material. Supplied strictly for in-vitro research and laboratory use only. Not for human or animal use.
Select Option
2+ save 5% · 5+ save 10% · 10+ save 20%
- Free Priority shipping on US orders over $100
- Ships same day on orders before 2 PM MST
- Plain, secure packaging
- Reported measurements · lot RET-20260811-02Bioviridian Inc. · COA7918: purity 99.68%; content 15.19 mg.
- Stock-solution arithmetic — Retatrutide concentration calculator
Batch Tracking
Batch #
RET-20260811-02
Tested
2026-08-23
Purity
99.68%
Method
RP-HPLC (214 nm)
Mechanism of Action
Retatrutide is a triple agonist at GLP-1R, GIPR and the glucagon receptor (GCGR). Li et al. (2024) determined cryo-EM structures of retatrutide bound to each receptor in complex with Gs and examined receptor mutations using cAMP signaling assays. The study identifies shared and receptor-specific peptide contacts in these experimental systems.
Properties
CAS Number
2381089-83-2
Half-Life
Not established
Storage
Store lyophilized at -20°C. Reconstituted at 2-8°C, use within 30 days.
Shipping & Delivery
- Same-day dispatch on orders placed before 2 PM MST (Arizona — no daylight saving).
- US shipping from $5. Free Priority on orders $100+ (before discounts).
- Plain, unmarked packaging — no branding or product names on the outside.
- Ships to all 50 states, DC, Puerto Rico & the U.S. Virgin Islands; tracking emailed on every order.
Quality & Testing
- Independently tested by Bioviridian Inc. — identity by LC-MS/MS, purity by RP-HPLC (214 nm).
- Reported measurements on lot RET-20260811-02:Bioviridian Inc. · COA7918: purity 99.68%; content 15.19 mg.
- USA-based; dispatched from Phoenix, Arizona.
- Supplied strictly for in-vitro laboratory research — not for human use.
Research Applications
References & Citations
(1)Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide
Li W, Zhou Q, Cong Z, et al.
Related Products
Research Use Only
This product is intended strictly for in-vitro research, educational, and laboratory use. Not for human consumption. The information provided is based on published research and does not constitute medical advice.